HSH2D Antikörper
-
- Target Alle HSH2D Antikörper anzeigen
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HSH2D Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human HSH2D. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product HSH2D Primärantikörper
-
anti-Hematopoietic SH2 Domain Containing (HSH2D) (AA 251-352) antibody
HSH2D Reaktivität: Human WB, ELISA, IHC (p) Wirt: Maus Monoclonal 1D6 unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) (AA 1-352) antibodyHSH2D Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) antibodyHSH2D Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) (AA 1-352) antibodyHSH2D Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) (Internal Region) antibodyVerified HSH2D Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) (AA 251-353) antibodyHSH2D Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 1D6 unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) (AA 267-316) antibodyHSH2D Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Hematopoietic SH2 Domain Containing (HSH2D) (C-Term) antibodyHSH2D Reaktivität: Human, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: NCI-H929
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Andere Bezeichnung
- hematopoietic SH2 domain containing (HSH2D Produkte)
- Synonyme
- ALX antikoerper, HSH2 antikoerper, Hsh2 antikoerper, wu:fk78a10 antikoerper, zgc:113273 antikoerper, hematopoietic SH2 domain containing antikoerper, HSH2D antikoerper, Hsh2d antikoerper, hsh2d antikoerper
- Hintergrund
- Hematopoietic SH2 domain containing , ALX , HSH2,T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor (see TCR, MIM 186880) and a costimulatory signal provided primarily by CD28 (MIM 186760) in naive T cells. HSH2 is a target of both of these signaling pathways (Greene et al., 2003 [PubMed 12960172]).[supplied by OMIM]
- Molekulargewicht
- 39 kDa
- Gen-ID
- 84941
- UniProt
- Q96JZ2
-
